Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: May 5, 2023
Open Peer Review Period: May 5, 2023 - May 22, 2023
Date Accepted: Jul 31, 2023
(closed for review but you can still tweet)
Consolidated reporting guidelines for prognostic and diagnostic machine learning modeling studies
ABSTRACT
Background:
The reporting of machine learning modeling prognostic and diagnostic studies is often inadequate, making it unnecessarily difficult to understand and replicate such studies. To address this, multiple consensus and expert reporting guidelines for such ML studies have been published. However, these guidelines cover different parts of the analytics life cycle and individually none of them provides a comprehensive set of reporting requirements.
Objective:
Consolidate the ML reporting guidelines in the literature for prognostic and diagnostic studies.
Methods:
A review and assessment of the literature on ML reporting guidelines identified 25 articles. These were consolidated by the authors into a single set of reporting items.
Results:
In total, 36 reporting items were identified. None of the source guidelines covered all 36 reporting items. Data and model evaluation guidelines were the most common in the source literature, with methodological guidance (i.e., data preparation descriptions of model training) had the least coverage in the literature.
Conclusions:
The items were converted into a checklist that can be used by authors, journal editors and reviewers to ensure consistency in reporting of ML modeling studies, and can also be used to score and monitor reporting quality. This is expected to improve understandability and reproducibility of work in this area.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.